The Food and Drug Administration (FDA) inspected New B. C. N. Trading, Inc. in South Plainfield on March 18 for foodborne biological hazards, according to data posted on the FDA’s website.
The final report stated that New B. C. N. Trading, Inc. was not required to implement any changes to its management operations.
The FDA regularly inspects facilities throughout the United States to ensure compliance with FDA-related laws designed to protect public health. Outcomes of these inspections are made available to the public.
As noted on its website, the FDA is a federal agency tasked with overseeing the safety and quality of human and animal drugs, biological products, medical equipment and tobacco products.
Information for this article was sourced from the U.S. Food and Drug Administration. Source data can be accessed here.
